BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32642684)

  • 1. The inflammatory microenvironment in vestibular schwannoma.
    Hannan CJ; Lewis D; O'Leary C; Donofrio CA; Evans DG; Roncaroli F; Brough D; King AT; Coope D; Pathmanaban ON
    Neurooncol Adv; 2020; 2(1):vdaa023. PubMed ID: 32642684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation.
    Mehta GU; Feldman MJ; Wang H; Ding D; Chittiboina P
    J Neurosurg; 2016 Dec; 125(6):1469-1471. PubMed ID: 26848914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparable tumour microenvironment in sporadic and
    Gregory GE; Jones AP; Haley MJ; Hoyle C; Zeef LAH; Lin IH; Coope DJ; King AT; Evans DG; Paszek P; Couper KN; Brough D; Pathmanaban ON
    Brain Commun; 2023; 5(4):fcad197. PubMed ID: 37680691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma Microenvironment.
    Hannan CJ; Lewis D; O'Leary C; Donofrio CA; Evans DG; Stapleton E; Freeman SR; Lloyd SK; Rutherford SA; Hammerbeck-Ward C; Brough D; Allan SM; Coope D; King AT; Pathmanaban ON
    J Neurol Surg B Skull Base; 2022 Feb; 83(1):1-10. PubMed ID: 35155063
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss.
    Tesařová M; Peterková L; Šťastná M; Kolář M; Lacina L; Smetana K; Hynek R; Betka J; Vlasák A; Lukeš P; Fík Z
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
    Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
    Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profile of cytokines and growth factors expressed in vestibular schwannoma and in normal vestibular nerve tissue.
    Taurone S; Bianchi E; Attanasio G; Di Gioia C; Ierinó R; Carubbi C; Galli D; Pastore FS; Giangaspero F; Filipo R; Zanza C; Artico M
    Mol Med Rep; 2015 Jul; 12(1):737-45. PubMed ID: 25738867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth.
    Bonne NX; Vitte J; Chareyre F; Karapetyan G; Khankaldyyan V; Tanaka K; Moats RA; Giovannini M
    J Neurooncol; 2016 Aug; 129(1):47-56. PubMed ID: 27177628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Grade Sarcoma Arising within a Previously Irradiated Vestibular Schwannoma: A Case Report and Literature Review.
    Boucher AB; Mendoza P; Neill SG; Eaton B; Olson JJ
    World Neurosurg; 2020 Dec; 144():99-105. PubMed ID: 32889192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutional LZTR1 mutation presenting with a unilateral vestibular schwannoma in a teenager.
    Gripp KW; Baker L; Kandula V; Piatt J; Walter A; Chen Z; Messiaen L
    Clin Genet; 2017 Nov; 92(5):540-543. PubMed ID: 28295212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21.
    Sadler KV; Bowes J; Rowlands CF; Perez-Becerril C; van der Meer CM; King AT; Rutherford SA; Pathmanaban ON; Hammerbeck-Ward C; Lloyd SKW; Freeman SR; Williams R; Hannan CJ; Lewis D; Eyre S; Evans DG; Smith MJ
    Brain; 2023 Jul; 146(7):2861-2868. PubMed ID: 36546557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and molecular pathology of vestibular schwannoma].
    Brodhun M; Stahn V; Harder A
    HNO; 2017 May; 65(5):362-372. PubMed ID: 27421984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular biology and novel treatments of vestibular schwannomas.
    Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
    J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostics and therapy of vestibular schwannomas - an interdisciplinary challenge.
    Rosahl S; Bohr C; Lell M; Hamm K; Iro H
    GMS Curr Top Otorhinolaryngol Head Neck Surg; 2017; 16():Doc03. PubMed ID: 29279723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
    Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
    J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis.
    Madhani AS; King S; Zhu J; Karmali F; Welling DB; Cai W; Jordan JT; Lewis RF
    Brain Commun; 2023; 5(2):fcad089. PubMed ID: 37025569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].
    Rosahl S; Bohr C; Lell M; Hamm K; Iro H
    Laryngorhinootologie; 2017 Apr; 96(S 01):S152-S182. PubMed ID: 29036751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the CNS manifestations of neurofibromatosis type 2.
    Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
    Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas.
    Van Gompel JJ; Agazzi S; Carlson ML; Adewumi DA; Hadjipanayis CG; Uhm JH; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E52-E54. PubMed ID: 29309638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
    Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
    J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.